Cognex Reiterated at Buy and 4 Reiterated Ratings to Recognize

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on October 2nd.

Cognex (NASDAQ:CGNX): Needham reiterated its rating of Buy for this company and changed its price target from $42 to $40.

Research In Motion (NASDAQ:RIMM): FBR Capital reiterated its rating of Underperform for this company and changed its price target from $6 to $6.5.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Celldex Therapeutics (NASDAQ:CLDX): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $6 to $8.

Vascular Solutions (NASDAQ:VASC): The Benchmark Company reiterated its rating of Buy for this company and changed its price target from $15 to $17.

Informatica (NASDAQ:INFA): Mizuho reiterated its rating of Buy for this company and changed its price target from $33.5 to $38.

Don’t Miss: RIM Earnings: Before and After.